Maris JM - Search Results

1

Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG.

Okamatsu C, London WB, Naranjo A, Hogarty MD, Gastier-Foster JM, Look AT, LaQuaglia M, Maris JM, Cohn SL, Matthay KK, Seeger RC, Saji T, Shimada H. Okamatsu C, et al. Among authors: maris jm. Pediatr Blood Cancer. 2009 Oct;53(4):563-9. doi: 10.1002/pbc.22106. Pediatr Blood Cancer. 2009. PMID: 19530234 Free PMC article.

2

Significance of chromosome 1p loss of heterozygosity in neuroblastoma.

Maris JM, White PS, Beltinger CP, Sulman EP, Castleberry RP, Shuster JJ, Look AT, Brodeur GM. Maris JM, et al. Cancer Res. 1995 Oct 15;55(20):4664-9. Cancer Res. 1995. PMID: 7553646

3

Biology and genetics of human neuroblastomas.

Brodeur GM, Maris JM, Yamashiro DJ, Hogarty MD, White PS. Brodeur GM, et al. Among authors: maris jm. J Pediatr Hematol Oncol. 1997 Mar-Apr;19(2):93-101. doi: 10.1097/00043426-199703000-00001. J Pediatr Hematol Oncol. 1997. PMID: 9149737 Review.

4

Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas.

Guo C, White PS, Weiss MJ, Hogarty MD, Thompson PM, Stram DO, Gerbing R, Matthay KK, Seeger RC, Brodeur GM, Maris JM. Guo C, et al. Among authors: maris jm. Oncogene. 1999 Sep 2;18(35):4948-57. doi: 10.1038/sj.onc.1202887. Oncogene. 1999. PMID: 10490829

5

Molecular biology of neuroblastoma.

Maris JM, Matthay KK. Maris JM, et al. J Clin Oncol. 1999 Jul;17(7):2264-79. doi: 10.1200/JCO.1999.17.7.2264. J Clin Oncol. 1999. PMID: 10561284 Review.

6

Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study.

Maris JM, Weiss MJ, Guo C, Gerbing RB, Stram DO, White PS, Hogarty MD, Sulman EP, Thompson PM, Lukens JN, Matthay KK, Seeger RC, Brodeur GM. Maris JM, et al. J Clin Oncol. 2000 May;18(9):1888-99. doi: 10.1200/JCO.2000.18.9.1888. J Clin Oncol. 2000. PMID: 10784629

7

Identification of a 1-megabase consensus region of deletion at 1p36.3 in primary neuroblastomas.

Hogarty MD, Liu X, Guo C, Thompson PM, Weiss MJ, White PS, Sulman EP, Brodeur GM, Maris JM. Hogarty MD, et al. Among authors: maris jm. Med Pediatr Oncol. 2000 Dec;35(6):512-5. doi: 10.1002/1096-911x(20001201)35:6<512::aid-mpo2>3.0.co;2-d. Med Pediatr Oncol. 2000. PMID: 11107105

8

Deletion of 11q23 is a frequent event in the evolution of MYCN single-copy high-risk neuroblastomas.

Guo C, White PS, Hogarty MD, Brodeur GM, Gerbing R, Stram DO, Maris JM. Guo C, et al. Among authors: maris jm. Med Pediatr Oncol. 2000 Dec;35(6):544-6. doi: 10.1002/1096-911x(20001201)35:6<544::aid-mpo10>3.0.co;2-2. Med Pediatr Oncol. 2000. PMID: 11107113

9

BIN1 inhibits colony formation and induces apoptosis in neuroblastoma cell lines with MYCN amplification.

Hogarty MD, Liu X, Thompson PM, White PS, Sulman EP, Maris JM, Brodeur GM. Hogarty MD, et al. Among authors: maris jm. Med Pediatr Oncol. 2000 Dec;35(6):559-62. doi: 10.1002/1096-911x(20001201)35:6<559::aid-mpo14>3.0.co;2-j. Med Pediatr Oncol. 2000. PMID: 11107117

10

Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma.

Thompson PM, Maris JM, Hogarty MD, Seeger RC, Reynolds CP, Brodeur GM, White PS. Thompson PM, et al. Among authors: maris jm. Cancer Res. 2001 Jan 15;61(2):679-86. Cancer Res. 2001. PMID: 11212268

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

457 results

Search Page